The U.S. Food and Drug Administration has approved Cinvanti (aprepitant) injectable emulsion, for intravenous infusion. Cinvanti is a substance P/neurokinin-1
Category: Intravenous infusion
Prevymn for intravenous infusion
Food and Drug Administration FDA has approved Prevymis (letermovir) once-daily tablets for oral use and injection for intravenous infusion. Prevymis
Kymriah for treating acute lymphoblastic leukemia
Kymriah (tisagenlecleucel) suspension for intravenous infusion, it is a prescription cancer treatment used in patients up to 25 years old
